Brimonidine Tartrate Ophthalmic Solution

FDA Drug Profile — Brimonidine Tartrate Ophthalmic Solution

Brimonidine Tartrate Ophthalmic Solution is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Brimonidine Tartrate Ophthalmic Solution. Available dosage form: solution/ drops.

Drug Details

Generic Name
Brimonidine Tartrate Ophthalmic Solution
Brand Names
Brimonidine Tartrate Ophthalmic Solution
Application Number
ANDA220398
Sponsor
Lifestar Pharma LLC
NDC Codes
3
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
BRIMONIDINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.